Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 09 Sep 2018
Price : $35 *
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 29 Dec 2016 Status changed from active, no longer recruiting to completed.
- 07 Apr 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 18 Jun 2014 New trial record